| Pamela Juliet Chambers, CRNA | |
|
501 N. North Navajo, Page, AZ 86040 | |
| (928) 645-0165 | |
| Not Available |
| Full Name | Pamela Juliet Chambers |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 501 N. North Navajo, Page, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922042936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 659231 (Texas) | Primary |
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association.
Dr. Mehmet Oz featured a breakthrough skin lifting and tightening procedure on his show today, which he said can help you defy gravity without going under the knife. The treatment, known as Ultherapy, was demonstrated live on an audience member on The Dr. Oz Show segment How to Look 10 Years Younger in Less Than 30 Minutes!
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world's first Laser PCR instrument based on the company's proprietary Pulse Controlled Amplification technology at the Analytica trade fair in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or less.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
› Verified 8 days ago
| Entity Name | Sunset Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841561347 PECOS PAC ID: 3779746375 Enrollment ID: O20120517000676 |
News Archive
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association.
Dr. Mehmet Oz featured a breakthrough skin lifting and tightening procedure on his show today, which he said can help you defy gravity without going under the knife. The treatment, known as Ultherapy, was demonstrated live on an audience member on The Dr. Oz Show segment How to Look 10 Years Younger in Less Than 30 Minutes!
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world's first Laser PCR instrument based on the company's proprietary Pulse Controlled Amplification technology at the Analytica trade fair in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or less.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
› Verified 8 days ago
| Entity Name | Coronado Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336569581 PECOS PAC ID: 4880814755 Enrollment ID: O20140929000987 |
News Archive
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association.
Dr. Mehmet Oz featured a breakthrough skin lifting and tightening procedure on his show today, which he said can help you defy gravity without going under the knife. The treatment, known as Ultherapy, was demonstrated live on an audience member on The Dr. Oz Show segment How to Look 10 Years Younger in Less Than 30 Minutes!
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world's first Laser PCR instrument based on the company's proprietary Pulse Controlled Amplification technology at the Analytica trade fair in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or less.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
› Verified 8 days ago
| Entity Name | Anesthesia Partners & Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336530997 PECOS PAC ID: 9931429198 Enrollment ID: O20150529000706 |
News Archive
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association.
Dr. Mehmet Oz featured a breakthrough skin lifting and tightening procedure on his show today, which he said can help you defy gravity without going under the knife. The treatment, known as Ultherapy, was demonstrated live on an audience member on The Dr. Oz Show segment How to Look 10 Years Younger in Less Than 30 Minutes!
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world's first Laser PCR instrument based on the company's proprietary Pulse Controlled Amplification technology at the Analytica trade fair in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or less.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
› Verified 8 days ago
| Entity Name | B--umg Tucson Ap Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487178505 PECOS PAC ID: 1355616517 Enrollment ID: O20171013002780 |
News Archive
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association.
Dr. Mehmet Oz featured a breakthrough skin lifting and tightening procedure on his show today, which he said can help you defy gravity without going under the knife. The treatment, known as Ultherapy, was demonstrated live on an audience member on The Dr. Oz Show segment How to Look 10 Years Younger in Less Than 30 Minutes!
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world's first Laser PCR instrument based on the company's proprietary Pulse Controlled Amplification technology at the Analytica trade fair in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or less.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Juliet Chambers, CRNA 2401 Northwind Dr, Little Elm, TX 75068-6853 Ph: (469) 362-0098 | Pamela Juliet Chambers, CRNA 501 N. North Navajo, Page, AZ 86040 Ph: (928) 645-0165 |
News Archive
Some of the key elements for success in the rapid treatment of heart attacks have been identified by researchers at Yale School of Medicine in a recent issue of Circulation: Journal of the American Heart Association.
Dr. Mehmet Oz featured a breakthrough skin lifting and tightening procedure on his show today, which he said can help you defy gravity without going under the knife. The treatment, known as Ultherapy, was demonstrated live on an audience member on The Dr. Oz Show segment How to Look 10 Years Younger in Less Than 30 Minutes!
GNA Biosolutions GmbH will be showcasing the Pharos V8, the world's first Laser PCR instrument based on the company's proprietary Pulse Controlled Amplification technology at the Analytica trade fair in Munich, Germany from April 10-13. Launched in November 2017, the Pharos V8 delivers ultrafast PCR results in 10 minutes or less.
Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced results from an in vitro study evaluating TBR-652 in combination with lopinavir (LPV), darunavir (DRV), atazanavir (ATV), tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the infectious replicative assay deCIPhR.
› Verified 8 days ago
Ms. Melissa Lynn Kolnik, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 501 N Navajo Dr, Page, AZ 86040 Phone: 928-645-2424 |